Clinical Trials Browser

Liver Neoplasms

NCT05743842 2026-03-09

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning

Phase NA Active not recruiting

19 enrolled

Gastrointestinal

Liver Neoplasms

NCT05953337 2026-03-04

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

Phase NA Active not recruiting

120 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT04258813 2026-02-20

ONE TEAM

Phase NA Active not recruiting

313 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Cardiovascular Diseases, Colonic Neoplasms, Diabetes Mellitus, Esophageal Neoplasms, Head and Neck Neoplasms, Hypercholesterolemia, Hypertension, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT04736121 2026-02-03

DOORwaY90

Phase NA Active not recruiting

100 enrolled

Gastrointestinal

Liver Neoplasms

NCT04573881 2026-01-12

#HOPE4LIVER

Phase NA Active not recruiting

24 enrolled 12 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01494324 2026-01-02

Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome

Phase NA Active not recruiting

150 enrolled

Gastrointestinal

Liver Neoplasms

NCT04572633 2025-11-19

#HOPE4LIVER US

Phase NA Active not recruiting

47 enrolled 15 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07214363 2025-10-09

The Safety and Efficacy of Irreversible Electroporation for the Treatment of Perivascular Liver Cancers

Phase NA Active not recruiting

20 enrolled

Gastrointestinal

Liver Neoplasms

NCT05128032 2025-10-08

PEDIR

Phase NA Active not recruiting

20 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Colorectal Neoplasms

NCT07207343 2025-10-03

Symptomatic Abdominal Tumors Are Unsuitable for Surgical Resection, High-intensity Focused Ultrasound (HIFU) Treatment Will be Applied to the Tumors. Postoperatively, Continuous Evaluation and Analysis of the Ablation Effect Will be Performed Using CT or MRI Imaging.

Phase NA Active not recruiting

38 enrolled

Gastrointestinal

Liver Neoplasms

NCT06384417 2025-08-08

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2

Phase NA Active not recruiting

32 enrolled

BreastDermatologicGastrointestinalHead & NeckThoracic

Breast Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

NCT03651154 2025-07-31

PRICE2

Phase NA Active not recruiting

440 enrolled

Gastrointestinal

Liver Neoplasms, Blood Loss, Surgical

NCT04186234 2025-07-29

SBRT for Liver Cancer Before Liver Transplantation

Phase NA Active not recruiting

71 enrolled

Gastrointestinal

Liver Neoplasms

NCT02984566 2025-04-04

TROG1703 LARK

Phase NA Active not recruiting

32 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05931445 2024-04-23

Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer

Phase NA Active not recruiting

500 enrolled

BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT04242342 2024-02-12

RASTAF

Phase NA Active not recruiting

46 enrolled

Gastrointestinal

Liver Neoplasms

Clinical Trials

STEREOLIVER

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

ONE TEAM

DOORwaY90

#HOPE4LIVER

Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome

#HOPE4LIVER US

The Safety and Efficacy of Irreversible Electroporation for the Treatment of Perivascular Liver Cancers

PEDIR

Symptomatic Abdominal Tumors Are Unsuitable for Surgical Resection, High-intensity Focused Ultrasound (HIFU) Treatment Will be Applied to the Tumors. Postoperatively, Continuous Evaluation and Analysis of the Ablation Effect Will be Performed Using CT or MRI Imaging.

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2

PRICE2

SBRT for Liver Cancer Before Liver Transplantation

TROG1703 LARK

Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer

RASTAF